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Abstract
The amyloid β peptide (Aβ42), whose aggregation is associated with Alzheimer’s
disease, is an amphiphatic peptide with a high propensity to self-assemble. Aβ42
has a net negative charge at physiological pH and modulations of intermolecular
electrostatic interactions can significantly alter its aggregation behaviour. Varia-
tions in sequence and solution conditions lead to varied macroscopic behaviour,
often resulting in a number of different mechanistic explanations for the aggrega-
tion of these closely related systems. Here we alter the electrostatic interactions
governing the fibril aggregation kinetics by varying the ionic strength over an order
of magnitude, which allows us to sample the space of different reaction mechanisms,
and develop a minimal reaction network that explains the experimental kinetics
under all the different conditions. We find that an increase in the ionic strength
leads to an increased rate of surface catalysed nucleation over fragmentation and
eventually to a saturation of this nucleation process. More generally, this reaction
network connects previously separate systems, such as mutants of Aβ42 and the
wild type, on a continuous mechanistic landscape, thereby providing a unified pic-
ture of the aggregation mechanism of Aβ42 and the means of directly comparing
the effects of intrinsic modifications of the peptide to those of simple electrostatic
shielding.
1 Introduction
Most functional proteins have a net charge under normal physiological conditions, which
helps confer solubility[1, 2, 3], and is governed by the protein sequence and structure,
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as well as the solution conditions such as pH, salt concentration and the concentration
of other charged species[4, 5, 6, 7]. The interactions involving charged and polar groups
modulate properties such as solubility, stability and reaction rates [8, 9, 10, 11, 12, 2].
In addition to their importance in the functional interactions of proteins, electrostatic
interactions play a key role in the formation of aberrant protein aggregates[13, 14, 15,
16]. In particular, charged proteins with embedded hydrophobic segments can be highly
aggregation-prone and their assembly into amyloid fibrils is associated with Alzheimer’s
disease (the Aβ peptide), Parkinson’s disease (the protein α-synuclein) and a range of
other debilitating human diseases. The aggregation kinetics of these proteins are strongly
influenced by electrostatic interactions and therefore depend on solution conditions and
the presence of species able to shield charges[17, 18].
Recent years have seen a significant advance in the mechanistic understanding of the
aggregation of disease-associated proteins under controlled conditions in vitro [19, 20, 21].
The mechanistic effects of variations in solution conditions, however, have often not been
characterised in detail and therefore only the part of the overall reaction network relevant
under a given set of conditions has been investigated. The individual systems under
different conditions are not linked together into a continuous mechanistic picture. A more
complete reaction network will be particularly important in vivo where aggregation-prone
proteins are found in the presence of a large number of other molecules, which modulate
their interactions.
Here, we present a method of sampling a large region of the reaction network of
an aggregating system by modulating electrostatic interactions. This approach provides
a means of altering the relative importance of different processes contributing to the
overall reaction network and thereby allows the sampling of a broad range of macroscopic
behaviour that can be explained by a single reaction network. In the present work
we investigate the aggregation kinetics of the 42-residue amyloid β peptide, Aβ42, at
different peptide and salt concentrations under quiescent conditions. We develop a model
that quantitatively accounts for the observed lag times, kinetic profiles and peptide
concentration dependences over the range of ionic strengths studied and rationalizes the
interplay of the individual microscopic rates and their dependence on the magnitude of
the electrostatic screening.
Results and Discussion
Monomeric Aβ42 has a net charge of between -3 and -4 at pH 8.0 where the C-terminus
and Asp, Glu, Lys and Arg side chains are mostly ionized and the His side chains
and the N-terminus may be partly protonated (Fig. 1a)[22, 23]. Due to interactions of
the charged groups, the specific value of the net charge is likely to change upon the
alteration of conformation and close packing associated with assembly of the peptides
into aggregates[24, 25]. The number of hydrophobic residues in the C-terminal segment
of Aβ42 (Fig. 1a) gives this peptide a high aggregation propensity, despite the strong
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electrostatic repulsion between individual monomers.
Figure 1: Amino acid sequence and aggregation data for Aβ42. a Hydrophobic residues
are shown in yellow, groups that are positively charged, negatively charged or having pK value
close to neutral pH are shown in blue (+), red (-) and green (n), respectively. b The kinetic
data for the aggregation of 3 µM Aβ42 in the presence of varying concentrations of salt,
measured by ThT fluorescence; three replicates at each salt concentration are shown. c Cryo
TEM images at a low (29 mM), intermediate (57 mM) and high (329 mM) ionic strength.
The fibrils were obtained by aggregation of solutions with a monomer concentration of 10
µM. (Note: the large circular objects are particles of ice.)
In the present study the aggregation kinetics of Aβ42 at monomer concentrations
ranging form 0.55 to 7 µM, and concentrations of up to 300 mM of added NaCl, in
4 mM phosphate buffer (giving an ionic strength of ≈12 mM in the absence of added
NaCl), were recorded in triplicate repeats by monitoring thioflavin T (ThT) fluores-
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cence (Fig. 1b). Fibrillar structures of similar morphology were found to be formed at
all monomer and salt concentrations as monitored by cryo electron microscopy (TEM)
(Fig. 1c), however, fibrils are packed more densely at higher salt concentrations. The
entire set of experiments was repeated with a fresh batch of purified peptide, at salt
concentrations in the same range, yielding similar results, which are shown in the SI,
Fig. S4, S5and S6. In order to analyse such a large body of kinetic data with a com-
plex underlying mechanism we first set out to obtain general constraints on possible
mechanisms by considering the qualitative features of the data.
Half Times and Scaling
The half time of the aggregation process is defined as the time by which half the final
aggregate concentration has formed. In the first instance, the value of the half time is
a guide to the aggregation propensity of a given system. For a charged peptide such as
Aβ42, the aggregation propensity is expected to increase as the electrostatic repulsion
between peptides becomes screened with increasing ionic strength. Indeed this acceler-
ating effect of salt on the overall reaction rate was observed at all peptide concentrations
examined in the present study, as is evident both from the kinetic curves in Fig. 1b
and from the monotonic decrease in half times with increasing ionic strength, Fig. 2b.
Similar results have been previously reported also for Aβ40 studied at a single peptide
concentration [22].
To go beyond this very qualitative result and obtain mechanistic information, we
consider the dependence of the half time t1/2 on the monomer concentration, described
by the scaling exponent γ where t1/2 ≈ mγ0 and m0 is the monomer concentration at
the beginning of an aggregation reaction. As outlined in Fig. 2a, the half time was de-
termined for each kinetic curve at each monomer and salt concentration. The variation
of the half time with varying salt concentration, at the same monomer concentration,
shows the increase in aggregation propensity with increasing ionic strength, Fig. 2b. By
contrast, from the variation of the half time with monomer concentration at the same
salt concentration, the scaling exponent[20] can be extracted, Fig. 2c, giving one scaling
exponent at each salt concentration. We observed that the average scaling exponent has
a biphasic dependence on the ionic strength, Fig. 2d; at low ionic strengths the half time
scales with γ =-0.7. As the ionic strength increases, the average scaling exponent reaches
a minimum of -1.4 at an ionic strength of around 32 mM and then increases again to
-0.6 at an ionic strength of 312 mM, the highest value used here. Therefore, as the ionic
strength is increased, the half times decrease monotonically for all monomer concentra-
tions, but the dependence of the aggregation rate on the monomer concentration, given
by the magnitude of the scaling, is largest at intermediate ionic strengths of circa 30
mM.
In addition we observe that at some salt concentrations there are variations in the scal-
ing exponent as the monomer concentration changes, resulting in curvature of the double
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Figure 2: Half time dependence on monomer and salt concentration. The top left
panel (a) shows a typical kinetic trace, in this case at a free monomer concentration of 3
µM and an ionic strength of 14.5 mM. The half time of aggregation can easily be extracted
from such traces and plots of its variation with varying salt or monomer concentration are
shown in the top right (b) and bottom left panels (c) respectively. The average slope of
the double logarithmic plot of half time against monomer concentration gives the scaling
exponent,γ, whose variation with ionic strength is plotted in the bottom right panel (d).
Note the curvature in (c), indicative of a scaling exponent that depends on the monomer
concentration.
logarithmic plots of half time versus monomer concentration: At low ionic strengths the
scaling exponent increases significantly in magnitude (i.e. the monomer dependence of
the reaction increases) as the monomer concentration is increased, for example from
γ = −0.5 to γ = −1.7 at an ionic strength of 14.5 mM, Fig. 2c. The opposite curvature
is evident at some higher ionic strengths where the scaling exponent decreases in mag-
nitude (i.e. the monomer dependence of the reaction decreases, Fig. 5) as the monomer
concentration increases.
In summary three distinct features emerge from this half time analysis: (1) The half
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times decrease with increasing ionic strength (as expected due to shielding of charge
repulsion between peptides). (2) The half time scaling with monomer concentration is
strongest at an ionic strength of approximately 30 mM and weaker at both lower and
higher ionic strengths. (3) At some ionic strengths, the scaling exponent depends on the
monomer concentration, i.e. there is curvature in double logarithmic plots of half time
versus monomer concentration.
Development of an aggregation model
We next set out to develop a unifying model that reproduces these half time features and
fits the time evolution of aggregate mass at all monomer and salt concentrations. Such a
model will allow a determination of the underlying reaction network of the aggregation
reaction and show how the dominant pathways through this network are shifted by
changes in ionic strength. In order to derive a quantitative description of the kinetics
of an aggregating system[26, 27], we have used a master equation approach[19, 20, 21]
that aims to classify all the processes that contribute significantly to the aggregation
reaction by their mathematical dependence on the monomer concentration, the overall
fibril number and the fibril mass concentrations.
The elongation of the ends of growth competent fibril by the addition of monomers
dominates the formation of fibril mass. In studies of the aggregation of other proteins,
this elongation step has been found to saturate[28], in our system, however, no saturation
effects are observed (see SI Fig. S8) hence elongation is modelled as a single step reaction.
Whereas the production of fibril mass is dominated by a single process, three classes of
processes are responsible for the formation of new aggregates and thereby new fibril ends
(see Fig. 3): (1) Processes that depend only on the monomer concentration, m(t), (e.g.
homogeneous nucleation of monomers in solution) which form new aggregates with rate
constant kn and are of reaction order nc in monomer concentration (referred to as primary
nucleation). (2) Processes that depend on the monomer concentration and the fibril mass
(e.g. heterogeneous nucleation on the fibril surface) produce new aggregates with rate
constant k2 and are of order n2 in monomer (referred to as secondary nucleation). (3)
Processes that depend only on the fibril mass (e.g. breakage of fibrils) and create new
free ends with rate constant k− (referred to as fragmentation). The latter two types of
event are referred to as secondary processes as they involve the catalysis of the formation
of new aggregates by existing aggregates.
Whilst primary nucleation and fragmentation may be assumed to be single step pro-
cesses, secondary nucleation consists of multiple steps in series, as we have established
previously[29]. The first step of secondary nucleation is a monomer-dependent attach-
ment step in which free monomers interact with the fibril surface and the second step
is a monomer-independent detachment of a newly formed nucleus. The overall process
can be dominated by either step, depending on the conditions, and the concentration at
which the second step becomes rate limiting, i.e. the concentration at which the fibril is
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Figure 3: A schematic depiction of the reaction network for the aggregation of Aβ42.
The general network (top), the special case when both fragmentation and unsaturated sec-
ondary nucleation are important (centre), resulting in a parallel network, and the special case
where saturation of secondary nucleation is important (bottom) but fragmentation is negli-
gible, resulting in a serial network. The ranges of scaling exponents covered by these models
as the monomer concentration increases are given below each model. The rate constants
given denote primary nucleation (kn), elongation (k+), depolymerisation (koff), fragmenta-
tion (k−), single-step secondary nucleation (k2), and the rates associated with multi-step
secondary nucleation: the monomer attachment (ka) and detachment rate constants (kd),
and the nucleus conversion/detachment rate constant (k¯2).
fully covered in bound monomers, is determined by the constant KM . By combining all
these processes the full reaction network of aggregation is obtained, as displayed at the
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top of Fig. 3.
Experiments in which the aggregation was monitored following the addition of monomeric
Aβ42 to preformed fibrils confirmed that the production of new aggregates in the present
system is dominated by secondary processes, as shown in detail in the SI (Fig. S7). Un-
der these conditions fragmentation and secondary nucleation produce significantly more
new aggregates than primary nucleation even at very low aggregate concentrations[30].
In order to simplify the fitting and analysis we have considered two special cases of this
general reaction network, differing in their mechanism of the secondary process: In the
first case both fragmentation and secondary nucleation, which act in parallel, may be
significant, but we assume that there is no significant saturation of secondary nucleation
(i.e. KM  m(t)n2). We will refer to this case as the parallel model and the corre-
sponding scheme is shown in Fig. 3. The second case allows for saturation of secondary
nucleation, but assumes that there is no significant contribution from fragmentation (i.e.
k2m(t)
n2  k−). We will refer to this case as the saturation model and the correspond-
ing scheme is shown in Fig. 3c. The detailed solutions to the kinetics of these models
(see Methods and SI) can be used to estimate the expected range of scaling exponents
which are shown below each model in Fig. 3.
Kinetic Analysis
We fitted both models to the experimental data, obtained as described above, simulta-
neously for all monomer concentrations at each ionic strength[21]. The parallel model
fits the data well at low and intermediate ionic strengths (see e.g. Fig. 4a), but becomes
invalid at high ionic strengths (see SI, Fig. S5). The saturation model fits the data at
intermediate and high ionic strengths (Fig. 4c), but fails to reproduce the data at low
ionic strengths (see Fig. 4b).
These results paint a clear picture of how the system goes through four distinct
regimes, each defined by which mechanism dominates the production of new fibrils as
the ionic strength increases (Fig. 5):
(I) At low ionic strengths (12 - 20 mM) the number of new growth competent ends pro-
duced by secondary nucleation and fragmentation is comparable (Fig. 5, 14.5 mM ionic
strength): At low monomer concentrations fragmentation produces the largest number of
new aggregates, resulting in a shallow dependence of the half time on monomer concen-
tration, i.e. a scaling exponent of between -0.5 and -1. At high monomer concentrations
secondary nucleation becomes the main source of new aggregates, resulting in a steeper
dependence of the half time on monomer concentration with a scaling exponent of around
-1.5. The average scaling exponent is circa -1.0.
(II) At intermediate ionic strengths (22 - 62 mM) fragmentation is negligible and
secondary nucleation is not yet saturated: The monomer dependence of the half times is
the same at all monomer concentrations, and the points in the double logarithmic plots
of half time versus peptide concentration in Fig. 5 at an ionic strength of 32 mM fall on
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Figure 4: Global fits of the aggregation curves. a and b The top panel shows a global
fit of equations 1 (a) and 3 (b) with three free parameters to the entire kinetic traces; shown
below is a fit of just the half time behaviour. The fit of the parallel model (a) is significantly
better than that of the saturation model (b), the mean squared error of the parallel model
being half of that of the saturation model. Note that the saturation model fails to reproduce
the correct half times, as it cannot produce a decrease in scaling exponent with increasing
monomer concentration. The saturation mechanism hence cannot explain the data at low
ionic strengths. c A fit of the saturation model at high ionic strengths shows good agreement
with the experimental data. For clarity not all sampled concentrations are displayed in the
plots of the full timecourses; the fits were, however, performed on the entire dataset. (See
the SI, Fig. S1, for plots of the full dataset and an explanation of the deviation of the parallel
model at high monomer concentrations.)
9
I: two in parallel II: single RDS III: two in series IV: single RDS
14.5 mM
γ = -1.7
γ = -0.5
monomer / μM0.5 1 2 4 6
40
20
10
4
2
1
0.4
t 1/
2 /
 h
8
monomer / μM0.5 1 2 4 6
γ= -1.3
γ = -0.9
92 mM
8
monomer / μM
0.5 1 2 4 6
γ = -0.7
162 mM
8
32 mM
monomer / μM
γ = -1.4
0.5 1 2 4 6 8
Increasing salt concentration / electrostatic shielding
Parallel model Saturation model
RDS
k2kd
ka
k2
k2
k-
kd
ka
k2
k2 =
Figure 5: Dependence of the mechanism on ionic strength. Double logarithmic plots
of half time versus initial monomer concentration for representative salt concentrations, one
from each of the four regimes detailed in the main text. Above each plot a schematic of
the secondary process dominating the aggregation network is displayed. The differing slopes
and curvature can be explained by considering which secondary mechanism dominates the
generation of new fibrils. From left to right: At an ionic strength of 14.5 mM, a combination
of fragmentation and secondary nucleation, with fragmentation dominating at low monomer
concentrations and secondary nucleation at high monomer concentrations results in negative
curvature. At an ionic strength of 32 mM, non-saturated secondary nucleation alone, i.e. a
single rate determining step (RDS), describes the data over the entire monomer range. At
an ionic strength of 92 mM, secondary nucleation saturates as the monomer concentration
increases, giving positive curvature. At an ionic strength of 162 mM, secondary nucleation
is fully saturated over the entire monomer concentration range, again requiring only a single
RDS.
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a straight line. In this region both the parallel and the saturation models are equally
valid. The average scaling exponent is close to its minimum value of -1.44.
(III) At ionic strengths beyond values where the average scaling exponent is at a
minimum (circa 92 mM) secondary nucleation starts to saturate: At low monomer con-
centrations it is barely saturated, giving a scaling exponent of circa -1.5, whereas at
high monomer concentrations saturation starts to become significant, giving a scaling
exponent of circa -1.0. Some curvature is evident in the half time plots (92 mM ionic
strength Fig. 5).
(IV) At high ionic strengths (162 mM and above) secondary nucleation is fully
saturated at all monomer concentrations investigated here. Repulsion between Aβ42
monomers is effectively screened and monomers have a high affinity to the fibril surface.
Detachment of newly formed nuclei becomes rate limiting during secondary nucleation.
The monomer dependence of the half times is constant with monomer concentration, the
half times in Fig. 5, at an ionic strength of 162 mM, can be seen to lie on a straight line.
Effect of Ionic Strength on Individual Microscopic Processes
The global fitting of the aggregation curves above provides an explanation of the observed
changes in half times and scaling exponents: the differential effect of a change in ionic
strength on the rates of the individual processes in the aggregation reaction leads to
shifts in the dominant mechanism of aggregate multiplication. In order to rationalize
this difference in susceptibility to electrostatic shielding we consider the variation of each
rate constant with ionic strength.
In the plots in Fig. 6a and b we show the logarithm of the various rate constant
versus the square root of ionic strength (this latter value includes the contribution from
the added salt as well as the buffer; in the absence of added salt the buffer alone (4 mM
sodium phosphate, 40 uM EDTA, pH 8.0) results in an ionic strength of approximately
12 mM). In a simple Debye-Hueckel (DH) [31, 32, 16] model of the effect of ionic strength,
these points would be expected to lie on a straight line. However, DH is accurate only at
low ionic strengths, which are not accessible experimentally due to the need for a buffer
to control the pH and issues of irreproducibility which emerge in experiments with very
slow aggregation rates and long lag times as observed at low ionic strengths. Straight
line fits up to an ionic strength of 100 mM are shown in Fig. 6, and although there is
significant deviation from linearity, we can use the value of the slope to obtain on order
of magnitude estimate of the charge of the species involved, as a consistency check. The
slope corresponds approximately to a product of the valency of the reacting ions. In case
of the elongation rate, Fig. 6a, the slope is approximately 6, which is determined by the
charge of a monomer and that of a free fibril end, consistent with a charge of -2 to -3 for
each of these species. In the case of the combined elongation-nucleation rate constant,
Fig. 6b, the slope is approximately 13. If we assume the contribution from elongation is
again approximately 6 (this is additive), the contribution from nucleation to the slope
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Figure 6: Effect of electrostatic screening on the microscopic rates. a The elongation
rate constant as measured in strongly seeded experiments (blue dots, experimental details in
SI). b The product of the elongation rate constant and the primary nucleation rate constant
at different ionic strengths, obtained from global fits of the specific aggregation model that is
valid at each ionic strength: Green dots from the parallel model (three lowest ionic strengths),
blue dots from the saturation model (three highest ionic strengths); the green-blue dots are
an average of the two models in the region of intermediate ionic strength where both models
converge to the same limiting case (three intermediate ionic strengths). c The Michaelis
constant, KM , as obtained from global fits of the saturation model at high ionic strengths
(the region where the saturation model is no longer valid is marked in red). As
√
KM gives the
monomer concentration at which saturation effects become important, the region of monomer
concentrations used in this study is marked in green. Values of KM outside the sampled region
are likely to be less accurate, as the variation of KM in this region will have very little effect
on the aggregation kinetics. The corresponding points are shown as empty circles. d Ratio
of the rates of production of new free ends from secondary nucleation and fragmentation at
ionic strengths of 14.5 mM, 32 mM and 162 mM, at monomer concentrations of 2 µM (light
blue) and 5 µM (dark blue). The ratio of fragmentation to secondary nucleation decreases
both with increasing monomer concentration and increasing ionic strength. At ionic strengths
of 162 mM and above, fragmentation is too slow to be measured.
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is then 7, which again is consistent with a charge of -2 to -3 for the monomers reacting
during primary nucleation (details see SI). Hence, although DH theory is inadequate
to describe fully the behaviour of charged macromolecules at the high ionic strengths
studied here, the estimates it yields for the charges of the reacting species are entirely
reasonable and hence consistent with an electrostatic effect.
Elongation rate constant: The fitting of data obtained in the absence of the addition
of any preformed fibrils yields the rate constants in the form of products, k+k2, k+kn
and k+k−, as the kinetics of such unseeded aggregation reactions depend only on these
combinations rather than on the rate constants individually. An estimate for the elonga-
tion rate constant, k+, can be obtained by performing experiments under strongly seeded
conditions and measuring the initial increase in aggregate mass, which is determined only
by the elongation of the seeds and not affected by nucleation processes. In order then
to extract the value for the elongation rate constant, the number of seed fibrils needs
to be determined. To this end, in the present study several TEM measurements were
performed in order to obtain an estimate of the average length of the fibrils. The fibril
lengths obtained in this way are only approximate and hence the elongation rates are
estimated to be accurate only to within an order of magnitude; the absolute value of k+
should therefore be interpreted with caution. Its relative variation with ionic strength
does, however, not suffer from such inaccuracies (details see SI). The elongation rate is
found to increase by approximately one order of magnitude as the ionic strength is varied
between 12 and 52 mM, Fig. 6a.
Nucleation rate constants: The product of the primary nucleation rate constant and
the elongation rate constant is the only quantity common to both models and hence can
be obtained for the entire range of salt concentrations from the global fits. In the region
of intermediate ionic strength (22 mM to 62 mM) the two models converge to the same
limit (single step secondary nucleation without fragmentation) and hence in Fig. 6b, in
the intermediate region, the average of the fits is shown. The combined primary nucle-
ation/elongation rate constant is found to increase by four orders of magnitude from the
lowest to the highest ionic strength, which implies an increase of the primary nucleation
rate constant by two to three orders of magnitude, and hence that primary nucleation
is affected more strongly than elongation by the electrostatic shielding. This may be
due to the fact that during primary nucleation a larger number of charged species come
together to form the nucleus. The secondary nucleation rate constant shows an increase
similar to that of the primary nucleation rate constant, whereas the fragmentation rate
constant remains approximately constant (plots see Fig. 6b and Fig. S5, Fig. S6). The
increase in the ratio of nucleation rate to elongation rate is also in agreement with the
decrease in fibril length observed in the TEM measurements (see SI, Fig. S9).
Saturation concentration: From fits of the saturation model, the monomer concen-
tration at which saturation of secondary nucleation occurs is found to decrease with
increasing ionic strength.
√
KM gives the monomer concentration at which saturation
effects become important: if
√
KM is above the region of monomer concentrations that
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are sampled in the experiment we expect the system to be unsaturated, if
√
KM is
within the region of monomer concentrations that are sampled we expect the system to
start displaying saturation as the monomer concentration increases, and finally if the
region of monomer concentrations that are sampled is above
√
KM we expect the system
to be fully saturated at all sampled monomer concentrations. The results show that√
KM decreases with increasing ionic strength, i.e. the system will begin to saturate at
lower monomer concentrations the higher the ionic strength (Fig. 6c). This observation
can be rationalised by considering the fact that the monomer concentration dependent
step in secondary nucleation involves an association reaction between negatively charged
monomers and negatively charged fibrils, which will be slower at lower ionic strengths. By
contrast the monomer independent detachment step is dominated by short range inter-
actions and rearrangements, which is therefore likely to be less affected by the screening
of electrostatic interactions. At high ionic strengths the first, monomer-dependent, step
becomes very fast, whereas the monomer-independent step proceeds at a rate similar to
that at low ionic strength, and therefore it becomes rate limiting, leading to the observed
saturation of secondary nucleation.
Dominant secondary process: Which of the two secondary processes dominates the
multiplication of aggregates is determined by both the ionic strength and the monomer
concentration. To illustrate this point, we have considered the relative number of new
aggregates produced by secondary nucleation and by fragmentation, at three different
ionic strengths and two monomer concentrations (Fig. 6d). At an ionic strength of 14.5
mM and low monomer concentrations, the ratio of fragmentation to secondary nucleation
is close to 1, and the two processes both contribute to the kinetics. At higher monomer
concentrations, secondary nucleation is faster, as its rate increases with monomer concen-
tration whereas fragmentation is independent of the monomer concentration. As the ionic
strength is increased to 32 mM, the rate of secondary nucleation increases significantly,
whereas the fragmentation rate does not match this increase, making the contribution of
fragmentation to the aggregation reaction insignificant even at low monomer concentra-
tions. At even higher ionic strengths, the fragmentation rate is too low to be detected
in the fitting.
Although the aggregation behaviour of Aβ42 is evidently complex over the entire salt
and monomer concentration ranges, it can be rationalised completely by considering the
effect of ionic strength in terms of an increase of the association rates of the various
microscopic processes. The more charged species associate in a given process, the more
it is affected by a change in ionic strength. The fact that this simple explanation is
sufficient to account for such a large range of complex behaviours strongly supports the
minimal mechanistic description of the aggregation process developed here.
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Table 1: Reaction network to unify variants of Aβ.
proposed mechanistic
system scaling mechanism analogue rationalisation
Aβ40[29] -1.2 to -0.5 saturating 2o nuc medium to high
ionic strength
decrease in de-
tachment rate
during 2o nuc
Aβ42, shaking[30] -0.6 fragmentation low ionic
strength, low
monomer con-
centration
increase in frag-
mentation due
to shear forces
Aβ42 A2V[33] -1.5 to -0.5 saturating 2o nuc medium to high
ionic strength
increased at-
tachment dur-
ing 2o nuc, due
to increased
hydrophobicity
Aβ42 pH7.4[33] -1.5 to -0.5 saturating 2o nuc medium to high
ionic strength
increased at-
tachment dur-
ing 2o nuc, due
to decreased
charge
Aβ42 N-term ext[34] approx -1.3 unsat 2o nuc medium ionic
strength
unchanged from
Aβ42
Aβ42 E22G[35] -0.5 fully sat 2o nuc high ionic
strength
increased at-
tachment dur-
ing 2o nuc, due
to decreased
charge
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Concluding remark
In this work we have shown that electrostatic screening can be used to modulate the
relative importance of different microscopic processes and thereby to alter the specific
pathway that dominates the conversion of soluble peptides to their amyloid forms. This
approach has allowed us to tackle a complex reaction network and to establish a mecha-
nistic framework that accounts fully for the aggregation behaviour of Aβ42 over a wide
range of solution conditions and monomer concentrations. As the individual rate con-
stants are altered by the increasing electrostatic shielding, modifying the interplay and
competition of the different microscopic processes, four distinct types of macroscopic
behaviour emerge. The rate of fragmentation is found to be largely unaffected by varia-
tions in ionic strength and only contributes notably at low ionic strengths and monomer
concentrations. By contrast, the rate constants for primary and secondary nucleation
each increase by approximately two orders of magnitude and the rate constant of elonga-
tion increases by circa one order of magnitude, upon increasing the ionic strength from
12 mM to 312 mM. The magnitude of the effect correlates with the number of charged
species that come together in the respective processes of nucleation (two or more), elon-
gation (two) and fragmentation (none). These findings show that the modulation of
electrostatic interactions has profound mechanistic effects beyond a simple overall in-
crease in aggregation propensity, and due to its differential effect on the individual rates
it represents a means to sample an extended reaction network.
The general reaction network we obtained here through this sampling of a large
proportion of the space of possible aggregation mechanisms serves as a unified framework
for describing the aggregation behaviour of the variants of the Aβ peptide. Indeed many
variants of Aβ under a range of conditions aggregate via a pathway that is part of
this general reaction network, summarised in table 1. Generally we find that effects
that increase the fibril coverage during secondary nucleation or increase the rate of
attachment of monomers to fibrils relative to the detachment of newly formed nuclei lead
to an aggregation mechanism that is dominated by a saturating, or saturated, secondary
nucleation mechanism, a process often associated with toxicity[36, 37]. This is the case
for the aggregation of Aβ42 at a slightly lower pH of 7.4[33], as well as the aggregation
of the mutants A2V[33] and E22G[35]. The reasons for increased fibril coverage in these
cases are believed to be a decreased electrostatic repulsion as more residues become
protonated at lower pH, a higher hydrophobicity and hence stronger binding of monomers
to fibrils for A2V, and again a lowering of the electrostatic repulsion due to the loss of a
charged sidegroup for E22G. This behaviour is analogous to the increased fibril affinity of
monomers we observed here at high ionic strengths. We previously found that the other
major variant of the Aβ peptide, Aβ40, aggregates via a saturating secondary nucleation
mechanism, however the overall rates are lower than in the case of Aβ42, possibly due to a
decreased nucleus formation / detachment step, rather than an increased binding, during
secondary nucleation. By contrast, N-terminally extended variants of Aβ42 aggregate
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via an unsaturated secondary nucleation mechanism, which is likely to be due to the
reduced number of reactive encounters of fibrils and monomers and therefore a saturation
of the fibril surface is not reached at the studied monomer concentrations[34]. Finally our
extended reaction network also connects the aggregation behaviour of Aβ42 under strong
agitation[30], with the behaviour under quiescent conditions: the shear forces induced
by shaking significantly increase the rate of fragmentation and the mechanism shifts to
one dominated by fragmentation. An analogous effect can be produced by significantly
lowering the rate of the other nucleation processes, as we have observed here at low salt
concentrations, allowing fragmentation to become kinetically visible.
The analysis detailed here, therefore, serves as a basis for interpreting how changes
in solution conditions or peptide sequence shift the dominant pathways in the reaction
network. It provides a continuum of mechanisms connecting the varied behaviour of
different systems. In particular it allows the determination of the extent to which any
alterations of the peptide sequence or the solution conditions correlate with those pro-
duced by altered electrostatic screening, thereby providing key insights into the physical
origin of any observed mechanistic differences.
Materials and methods
Aβ42 Expression and Purification
Aβ(M1-42), of sequence shown in Fig. 1, here referred to as Aβ42, was expressed in
E. coli from a synthetic gene and purified in batch format using ion exchange and size
exclusion steps as described in Walsh et. al [38]. This results in highly pure monomeric
peptide, which was divided in identical aliquots and stored as lyophilized peptide powder.
Samples for aggregation kinetics
Monomeric Aβ42 was isolated twice by gel filtration of aliquots of purified peptides just
prior to preparing each of the experiments, to remove any traces of aggregates formed dur-
ing freezing and thawing and to exchange the buffer. The peptide powder was dissolved
in 6 M GuHCl at pH 8.0 and the monomer peak was collected in low-bind Eppendorf
tubes (Axygene) on ice and the concentration was determined by absorbance at 280 nm
using an extinction coefficient of 1440 l mol−1 cm−1. Gel filtration was performed in 20
mM sodium phosphate, 0.2 mM EDTA, pH 8 at high enough concentrations that the
isolated monomeric peptide could be diluted 5-fold with water or NaCl and still contain
monomer concentrations of up to 5-7 µM. The final solutions used in the aggregation
assays contained 4 mM sodium phosphate buffer, pH 8.0, with 40 µM EDTA, 6 µM ThT
and NaCl in the range between 0 to 300 mM. The monomer concentration was varied
between 0.5 and 7 µM and the ThT concentration (6 µM) was chosen to be in the range
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that has been shown to provide a response that is linearly dependent on the total aggre-
gate mass [30]. Here, this linearity was found to hold at all salt concentrations. At 0-10
mM NaCl the fluorescence intensity is higher the lower the salt concentration, but the
response still varies linearly with monomer concentration for each salt concentration. All
solutions used in gel filtration and in the preparation of sample series were extensively
degassed. The aggregation kinetics were studied at 37oC under quiescent condition by
recording the ThT fluorescence intensity as a function of time using a plate reader (Flu-
oStar Omega or Optima, BMG Labtech, Offenberg, Germany). The fluorescence was
recorded in half-area 96-well PEG-coated black polystyrene plates with clear bottoms
(Corning 3881, Massachusetts, USA) measuring from below with a 440 nm excitation
filter and a 480 nm emission filter.
Theoretical Model
The time evolution of aggregate mass, M(t), for the parallel model is given by:
M(t) = mtot + exp
[
−k+(4cκcosh(κt) + 4P0κ
2sinh(κt))
2κ3
]
(
(M0 −mtot)e
2k+c
κ2
)
(1)
where
a = k2m
n2
0 + k−
c = knm
nc
0 + aM0
κ =
√
2k+m0(k2m
n2
0 + k−) (2)
where mtot is the total protein concentration, M0, P0 and m0 are the initial mass con-
centration of fibrils, number concentration of fibrils and monomer concentration, respec-
tively. k+, k−, kn and k2 are the rate constants of elongation, fragmentation, primary
nucleation and secondary nucleation.
For the saturation model we obtain:
M
M∞
= 1−
(
1− M0
M∞
)
e−k∞t
·
(
B− + C+eκt
B+ + C+eκt
· B+ + C+
B− + C+
) k∞
κk¯∞
(3)
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where the definitions of the parameters are
κ =
√
2m0k+
mn20 k2
1 +mn20 /KM
(4)
λ =
√
2k+knm
nc
0 (5)
C± =
k+P0
κ
± k+M0
2m0k+
± λ
2
2κ2
(6)
k∞ = 2k+P∞ (7)
k¯∞ =
√
k2∞ − 2C+C−κ2 (8)
B± =
k∞ ± k¯∞
2κ
(9)
Again m0 is the initial monomer concentration, P0, M0 and P∞, M∞ are the aggregate
number and mass concentrations at the beginning of the reaction and at equilibrium,
i.e. after completion of the aggregation reaction. The details of the derivation of these
models can be found in the SI.
Note that for unseeded experiments (i.e. experiments starting from monomer alone,
without preformed fibrils) the two limiting cases only involve three free parameters each
(k+k2, k+kn and k+k− for the parallel model and k+k2, k+kn and KM for the saturation
model), which were found to be sufficient in the present study to produce high quality
global fits to all monomer concentrations at any given salt concentration. For the parallel
model, the scaling exponents is given by:
γcomp =
d log(t1/2)
d log(m(0))
≈ −1
2
(
n2
1 +K/m(0)n2
+ 1
)
(10)
where K = k−/k2. This expression interpolates between γ = −1/2 and γ = −(n2 + 1)/2
for the limits of low and high monomer concentration respectively, giving the negative
curvature in the double logarithmic plots of the half time, as predicted from the quali-
tative argument used to derive the general constraints above.
For the saturation model, the scaling exponent is given by:
γsat ≈ −1
2
(
n2
1 +m(0)n2/KM
+ 1
)
(11)
where KM is the Michaelis constant. This expression interpolates between γ = −(n2 +
1)/2 and γ = −1/2 for the limits of low and high monomer concentration respectively,
i.e. the reverse of the parallel model.
Fitting
The data were normalised to give units of relative fibril mass concentration. The fits were
performed using a basin-hopping algorithm[39, 29] on the AmyloFit fitting platform[21].
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There were three global (i.e. one value of each parameter for all monomer concentrations)
fitting parameters at each salt concentration: knk+,k2k+ and k−k+ for the parallel model,
and knk+,k2k+ and KM for the saturation model. The reaction orders of primary and
secondary nucleation, nc and n2, were both fixed to 2, in line with the values found for
Aβ42 in previous work[30]. The effect of fitting the reaction orders, which were set to
the value previously established at a single salt concentration[30], is discussed in the SI.
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1 Additional fits and datasets
1.1 Full datasets from Fig. 4
For clarity we showed only part of the dataset in the fits in Fig. 4of the main text. The
full datasets are shown here in Fig. S1. Note that the fits shown in the main text were
also performed on the entire dataset, i.e. they are the same as the ones shown here, some
concentrations were simply omitted for clarity.
1.2 Fitting reaction orders
In the main text we noted a slight deviation of the parallel model in both half times and
fits at high monomer concentrations, Fig. 4. This may in fact be due to a small increase
in the reaction order of secondary nucleation, e.g. due to an increase in secondary nucleus
size. A freely varying n2 achieved fits to the experimental data within error, as shown
in Fig. S2, with a value of n2 ≈ 4. However, the improvement in the fit is small and all
other salt concentrations fit well to a value of n2 = 2. In addition a constant value of
n2 across the salt concentration allows for better comparison of the fitted rates. In the
main text we therefore chose to keep n2 fixed to a value of 2.
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Figure S1: Fits from Fig. 4. In Fig. 4only part of the dataset was shown, here we
display all monomer concentrations for the fits of the parallel model to the data at 2.5
mM salt and the fits of the saturation model to the data at 150 mM salt.
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Figure S2: Fit of the full kinetic curves at 2.5 mM salt with n2 as a free
parameter. On the left the secondary nucleation reaction order,n2, is fixed to 2, which
is the case used in the main text, on the right n2 is left to vary during the fitting. n2
converged to a value of 4, when left to vary, yielding slightly improved fits compared to
the case of n2 = 2.
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1.3 Detailed variation of rates with salt for each model.
The entire experimental setup was repeated and Fig. S3 shows the scaling exponent ob-
tained from the second set of experiments and is in agreement with the findings of the
first set of experiments. In Figs. S4, S5 and S6, the rates from fits of both models at
all salt concentrations are shown. The entire setup was performed twice, labelled set 1
and set 2 in the figures, the results from the two datasets agree well. By considering
the saturation of secondary nucleation at high salt we can now explain the disconti-
nuity observed in the parameters for the parallel model: At high salt concentrations
the secondary nucleation process is saturated at all monomer concentrations. In a fully
saturated system the term for secondary nucleation has no monomer dependence and
becomes k2
m(t)n2
1+m(t)n2/KM
M(t) → k2KMM(t) (details see section ”‘Limits of models”’ )
which is equivalent to a system purely determined by fragmentation, with fragmentation
rate constant k− = k2KM . Hence the parallel model yields good, purely fragmentation
dominated fits at high salt concentrations, but the fragmentation rate constant obtained
from the fit is in fact the saturated secondary nucleation rate constant, meaning that
the discontinuities in k− and k2 in the parallel model results from the fact that we are
fitting to actual fragmentation at low salt concentrations and misinterpreting saturated
secondary nucleation as fragmentation at high salt concentrations.
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Figure S3: Variation of the average scaling exponent. This is equivalent to the
plot in Fig. 2c in the main text, for the repeat dataset, and shows very similar results.
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Figure S4: Variation of the combined primary nucleation-elongation rate con-
stant. This is the equivalent of Fig. 6b in the main text, for the repeat dataset, and
shows very similar results.
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Figure S5: Variation of the microscopic rates with salt concentration for the
parallel model. The region in which the fragmentation model is no longer valid
(above approximately 50 mM salt) is marked in red. The top panels show the com-
bined fragmentation-elongation rate constant. The bottom panels show the combined
secondary nucleation - elongation rate. Note the major discontinuity in k+k2 (15 orders
of magnitude), which marks the breakdown of the parallel model, i.e. when saturated
secondary nucleation is suddenly interpreted as fragmentation as explained in detail in
the text. In the region of validity, k+k2 increases by several orders of magnitude, whereas
k+k− only increases by one order of magnitude. As the elongation rate constant was in-
dependently determined to increase by one order of magnitude, the increase in k+k− can
hence be attributed purely to the increase in elongation. Therefore the fragmentation
rate depends only weakly on the salt concentration, whereas the secondary nucleation
rate constant (also confirmed by the saturation model) increases significantly with in-
creasing salt concentration.
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Figure S6: Variation of the microscopic rates with salt concentration for the
saturation model. The region in which the saturation model is no longer valid (below
approximately 10 mM salt) is marked in red. The top panels show the combined sec-
ondary nucleation-elongation rate constant. The bottom panels show the square root of
the Michaelis constant, i.e. the concentration at which saturation effects are most signifi-
cant. In its region of validity, the secondary nucelation rate constant increase by about 2
orders of magnitude, the elongation rate constant, which was determined independently,
shows only a weak increase in this region, hence secondary nucleation is clearly favoured
by an increase in salt concentration. The Michaelis constant displays erratic behaviour
in the region where the saturation model is not valid, as these values were obtained from
missfits. In its region of validity there is a clear trend going from an unsaturated system,
with saturation concentrations above the highest sampled monomer concentrations, to
a saturated system, with saturation concentrations below the lowest sampled monomer
concentrations.
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2 Theoretical Background and Detailed Solutions
Model derivation We make two basic assumptions, first that the increase in fibril
mass is proportional to the number of fibrils (this is motivated by considering addition
to the ends of fibrils only; the area and structure of the ends is not expected to change
with fibril length) and that the processes creating new fibrils are proportional to the total
fibril mass (what we will call secondary processes; this includes fibril surface catalysed
nucleation and fragmentation of fibrils). Using simple chemical kinetics we can then
derive differential equations, the moment equations, describing the time evolution of
fibril number concentration, P (t), and fibril mass concentration, M(t).
dP
dt
= knm(t)
nc + k−(M(t)− (2nc − 1)P [t]) + k2 m(t)
n2
1 +m(t)n2/KM
M(t) (S1)
dM
dt
= 2m(t)k+P (t) (S2)
The origin of the terms in equation (S1) from left to right is primary nucleation, frag-
mentation and secondary nucleation. In previous work [4] it was shown that secondary
nucleation may saturate at high monomer concentrations, i.e. become monomer inde-
pendent. This is reflected in the term m(t)
n2
1+m(t)n2/KM
which originates from a treatment of
secondary nucleation as a Michaelis-Menten like process resulting in saturation kinetics:
At low monomer concentrations secondary nucleation depends on monomer to the power
of n2 (
m(t)n2
1+m(t)n2/KM
≈ m(t)n2), whereas at high monomer concentrations it is independent
of monomer concentration ( m(t)
n2
1+m(t)n2/KM
≈ KM). The Michaelis constant KM determines
at which concentration this change of behaviour occurs.
The solution to these equations in the limit KM → ∞ (parallel model) is outlined
below and in the limit k− → 0 (saturation model) it is found in ”Differences in nucleation
behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides”
[4].
For the parallel model the system of differential equations to solve becomes:
dP
dt
= knm(t)
nc + k−M(t) + k2m(t)n2M(t) (S3)
dM
dt
= 2m(t)k+P (t) (S4)
where we ignored the term −(2nc−1)P [t] for clarity. It accounts for the fibrils lost when
a piece smaller than the critical nucleus breaks off and dissolves, which is negligible for
the small nucleus size at hand. We find the early time solution to these equations by
setting m(t) = m(0); this linearises the equations and makes them easily solvable. Then,
by integrating equation S3 we obtain a fixed point operator and substitute the early time
solution as an initial guess into this fixed point operator to yield the first order solution
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for M(t). This follows the strategy outlined in detail in Cohen et al.(2011) [2, 1]. The
approximate solution obtained in this way is given by:
M(t) = mtot + Exp
[
−k+(4cκCosh(κt) + 4P0κ
2Sinh(κt))
2κ3
]
(
(M0 −mtot)e
2k+c
κ2
)
(S5)
where
a = k2m
n2
0 + k−
c = knm
nc
0 + aM0
κ =
√
2k+m0(k2m
n2
0 + k−) (S6)
where mtot is the total protein concentration, M0, P0 and m0 are the initial mass concen-
tration of fibrils, number concentration of fibrils and monomer concentration respectively,
k+, k−, kn and k2 are the rate constants of elongation, fragmentation, primary nucleation
and secondary nucleation.
Note that for unseeded experiments the two limiting cases only involve 3 free pa-
rameters each (k+k2, k+kn and k+k− for the parallel model and k+k2, k+kn and KM for
the saturation model) which are sufficient to produce good global fits to all monomer
concentrations at any given salt concentration.
For the parallel model the scaling exponents is given by
γcomp =
d log(t1/2)
d log(m(0))
≈ −1
2
(
n2
1 +K/m(0)n2
+ 1
)
(S7)
where K = k−/k2. This interpolates between γ = −1/2 and γ = −(n2 + 1)/2 for the
limits of low and high monomer respectively, giving the negative curvature in the double
logarithmic plots of the half time, as predicted from the qualitative argument used to
derive the general constraints above.
For the saturation model the scaling exponent is given by
γsat ≈ −1
2
(
n2
1 +m(0)n2/KM
+ 1
)
(S8)
where KM is the Michaelis constant. This interpolates between γ = −(n2 + 1)/2 and
γ = −1/2 for the limits of low and high monomer respectively, i.e. the reverse of the
other model.
Limits of models A fully saturated system in the saturation model (m(t)n2  KM)
is mathematically equivalent to a purely fragmentation dominated system in the parallel
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model (k−  k2m(t)n2) as they both include a single, monomer-independent secondary
process. This explains why reasonable fits of the parallel model were achieved at high
salt concentrations, albeit with a discontinuity in the fitted rates compared to lower
salt, because saturated secondary nucleation was missinterpreted as fragmentation by
the fitting, leading to unrealistic behaviours of the associated rates.
Equally, a completely unsaturated system in the saturation model (m(t)n2  KM) is
mathematically equivalent to a purely secondary nucleation dominated system in the par-
allel model (k−  k2m(t)n2) as they both include one single-step, monomer-dependent
secondary process. However, because the analytical solutions given above are approxi-
mate, they do in fact not converge to exactly the same solutions in these limits. The
solution to the parallel model is obtained through one fixed point iteration of the early
time linearised solutions, whereas the saturation model is obtained from one fixed point
iteration of a slightly improved initial guess [2, 1, 4], meaning that the saturation model
analytical solutions are more accurate, although this effect is minor under most condi-
tions. However this may be one of the reasons the fits in the region where both models
are valid do not agree perfectly.
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3 Seeded experiments and analysis
3.1 Low concentration seeding
In order to confirm that secondary processes do indeed dominate at all salt concentra-
tions, we performed seeded experiments at very low seed concentrations (nM). If the
system is dominated by primary nucleation this addition of a very small concentration
of seed material has little effect and the half times are expected to remain unchanged.
However, if the system is dominated by secondary nucleation these seeds catalyse the for-
mation of more seeds in the positive feedback mechanism of secondary nucleation. This
leads to a significant effect on the half times as is apparent at all tested salt concentration,
see Fig. S7.
80 mM salt 150 mM salt
0 mM salt 5 mM salt
Figure S7: Effect of low seeding at different salt. The aggregation of 3 µM Aβ42
at a number of salt concentrations between 0 mM and 150 mM NaCl. The curves at
low salt are normalised and averaged over triplicate repeats for reasons of clarity as
the variations at these concentrations are large. For the higher salt concentrations the
individual curves are shown. In all cases 1.2 nM seeds, corresponding to 0.04% of the
monomer concentration present, already lead to a significant shortening of the half time,
confirming secondary nucleation is dominant.
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3.2 Determination of elongation rate constant
The estimation of the elongation rate also follows the methods described in [4]: Strongly
seeded experiments, at a seed concentration of 2 µM and a monomer concentrations
ranging from 1 to 6 µM were performed at salt concentrations of 1, 10, 31, 80 ,150, and
300 mM (ionic strengths are 12 mM higher due to the presence of buffer). The initial
gradient, dP/dt|t=0 = 2k+P0m(t), at the different monomer concentrations was used to
extract the constant of proportionality, 2k+P0, relating the initial rate to the monomer
concentration. This moreover serves as a check for saturation of the elongation rate: If
the elongation rate does saturate, then the increase of the initial gradient with monomer
concentration is not linear, but plateaus above a certain monomer concentration. No
evidence of such a plateau was observed, even at the highest salt concentrations, as
evident in Fig. S8. In order to determine the absolute value of the elongation rate
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Figure S8: Initial gradients from strongly seeded experiments. The initial gra-
dients from strongly seeded experiments (2 µM seeds), show a linear dependence on the
monomer concentration, even at high ionic strengths, suggesting that the elongation rate
is not yet beginning to saturate. The factor of proportionality relating the initial gradient
to the monomer concentration can be used to determine the elongation rate constant.
constant, k+, from this, P0 needs to be estimated. The average number of monomers per
seed fibril, L0, relates the initial fibril mass concentration, M0, to the initial fibril number
concentration, P0, by P0 = M0/L0. The fibril mass concentration is known and L0 can
be determined from a measurement of fibril dimensions by TEM. Fig. S9 shows a table
of the average dimensions of fibrils at the different salt concentrations. By assuming a
density of protein of 1.3 g/ml these dimensions can be used in order to calculate the
number of monomers per seed fibril, which is plotted in Fig. S9. The absolute values are
likely to be very approximate, due to various biases in the extraction of fibril lengths:
larger fibrils are harder to detect, as the likelihood of being able to detect both ends is
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smaller. Moreover fibrils can form tangles, which will make the ends less accessible and
thereby increase the number of fibrils per growth competent end, L0. However, if we
assume this effects similarly affect all salt concentrations, the observed trend will be more
reliable than the absolute values. This equally translates to the trend of the elongation
rate constant with increasing salt: although its absolute value is inaccurate due to the
errors associated in determining the seed length, its increase by an order of magnitude
is significant. The error bars shown in Fig. 6are hence determined by the inaccuracies in
measuring the initial gradient and in extrapolating the seed length to salt concentrations
not measured explicitly (Fig. S9).
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Figure S9: Determination of fibril dimensions from TEM. A slight decrease in
fibril length upon increase in ionic strength can be observed. This trend is in agreement
with our finding that the elongation rate increases less than the nucleation rates, leading
to a shorter equilibrium fibril length.
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4 Further experimental and theoretical techniques
4.1 Error estimation
The error estimation was based on the method described in [4]: All experiments were
performed as triplicate repeats, therefore in order to obtain an estimate of the error in
the rate constants due to experimental variations, we considered subsets of the data,
including one repeat only at each monomer concentration. These subsets were fitted
normally and the resulting values of the rate constants were averaged and their standard
deviation used to obtain an estimate of the error.
4.2 Fitting algorithm
The fitting was performed using our protein aggregation fitting software, AmyloFit[3],
which can be found at www.amylofit.ch.cam.ac.uk. It employs a basin hopping algorithm
[5], which consists of a local minimisation paired with a Monte-Carlo step to randomise
initial guesses. This algorithm thereby effectively flattens the potential energy landscape
and allows the fit to converge to the global minimum even if the initial guess was not
in the correct basin of attraction. Such a property is important in the global fitting of
large datasets to complex equations as these situations tend to result in rough energy
landscapes and convergence to local rather than the global minimum can be an issue.
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